BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Date iCal//NONSGML kigkonsult.se iCalcreator 2.20.2//
METHOD:PUBLISH
X-WR-CALNAME;VALUE=TEXT:UMCES Events
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:STANDARD
DTSTART:20191103T020000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20200308T020000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:calendar.3940.field_date_time.0@www.umces.edu
DTSTAMP:20260418T102034Z
CREATED:20190626T135201Z
DESCRIPTION:October 16\, 2019 3:00pm to 4:00pm    \n    \n      \n\n\n    
 \n\n              \nInstitute of Marine & Environmental Technology\n      
 \n\n\n\n\n  \n\n    \n\n              \n\n\n      \n  \n\n    \n\n        
       \n\n\nTitle: Novel signaling mechanisms that lead to resistance of c
 ell wall reactive antibiotics in Staphylococcus aureus\n\n\n\nSpeaker: Dr.
  Som Chatterjee (Assistant Professor\, UMB-IMET)\n\n\n\nAbstract: Staphylo
 coccus aureus is an important bacterial pathogen that can cause severe inf
 ections to humans. Cell wall reactive antibiotics\, such as beta-lactams\,
  is one of the gold standards for treatment of bacterial infections due to
  their efficacy and safety of use in clinics. Resistance to beta-lactams m
 akes it often very difficult for it to be used for therapy.  We have recen
 tly identified that the second messenger Cyclic-Di-AMP (CDA) and a Serine-
 Threonine Kinase (STK) signaling system play a crucial role in beta-lactam
  resistance in S. aureus.  Currently the lab is focused to determine the m
 echanisms through which CDA and STK mediate resistance against beta-lactam
  drugs.\n\n\n\nHost: Dr. Frank Robb
DTSTART;TZID=America/New_York:20191016T150000
DTEND;TZID=America/New_York:20191016T160000
LAST-MODIFIED:20190912T123708Z
SUMMARY:IMET Seminar: Dr. Som Chatterjee (Assistant Professor\, UMB-IMET)
URL;TYPE=URI:https://www.umces.edu/events/imet-seminar-dr-som-chatterjee-as
 sistant-professor-umb-imet
END:VEVENT
END:VCALENDAR
